#drugdiscovery #drugdevelopment #drugdiscoveryanddevelopment To view or add a comment, sign in FDA accepts license application for a treatment of generalised pustular psoriasis The US Food and Drug Administration (FDA) has accepted the filing of a Biologics License Application (BLA) for imsidolimab for the treatment of generalised pustular psoriasis (GPP), with a target action date of 12 December 2026
Expertise: You are under the care of medical professionals specialized in GLP-1 clinic Illinois protocols
Foods rich in sulfur, such as cruciferous vegetables, garlic, and onions, provide the necessary sulfur-containing amino acids to drive synthesis
29 Dec 2021: I (RLB) respond: OMG what a ride
For those using insurance: Ivm Health will contact your insurance provider to confirm specific coverage details Understand your copay and out-of-pocket expenses Choose a pharmacy that has your medication and dose in stock Complete required paperwork promptly Schedule follow-up appointments as recommended For self-pay patients or those using HSA/FSA funds for GLP-1 medications: Complete payment using your preferred method Wait for follow-up pharmacy communication Prepare for medication delivery Plan for regular check-ins with your healthcare team For self-pay patients or those using Klarna: Select Klarna as your preferred payment method Wait for follow-up pharmacy communication Prepare for medication delivery Plan for regular check-ins with your healthcare team Long-Term FSA/HSA Eligible Weight Loss Support Your weight loss journey extends beyond just starting medication
Mutagenesis 14(1):3136 Hanigan MH, Frierson HF Jr, Swanson PE, De Young BR (1999) Altered expression of gamma-glutamyl transpeptidase in human tumors
